Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs > Financing Thoughts

<< Previous

Bullboard Posts

Next >>

Comment by waynedon Dec 08, 2010 5:25pm

249 Views

Post# 17820624

RE: RE: Financing Thoughts

I have to agree that this is the best thing all around . Nobody in this business does anything for free. This is how its done and this is how money is raised. In the HudBay release this afternoon they state they have the right to keep their percentage up in all future financings. They must feel Halo is a pretty important asset if they are already making sure it never gets away from them.
In a few months they present holders are going to look pretty smart.
Check out the price of zinc and copper.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario